GSK-3抑制剂XIII
|
G338805-25mg
|
Moligand™, ≥98% |
404828-08-6 |
25mg
|
¥ 6179.9
|
期货,请咨询 |
阿拉丁 |
GSK-3抑制剂XIII
|
G338805-10mg
|
Moligand™, ≥98% |
404828-08-6 |
10mg
|
¥ 2986.9
|
期货,请咨询 |
阿拉丁 |
GSK LSD1二盐酸盐
|
G338771-25mg
|
Moligand™, ≥98% |
1431368-48-7 |
25mg
|
¥ 1389.9
|
现货 |
阿拉丁 |
GSK LSD1二盐酸盐
|
G338771-100mg
|
Moligand™, ≥98% |
1431368-48-7 |
100mg
|
¥ 3706.9
|
现货 |
阿拉丁 |
GW2974
|
G337820-5mg
|
≥98% |
202272-68-2 |
5mg
|
¥ 648.9
|
期货,请咨询 |
阿拉丁 |
GW2974
|
G337820-50mg
|
≥98% |
202272-68-2 |
50mg
|
¥ 2678.9
|
期货,请咨询 |
阿拉丁 |
GW2974
|
G337820-10mg
|
≥98% |
202272-68-2 |
10mg
|
¥ 1029.9
|
期货,请咨询 |
阿拉丁 |
愈创木烯
|
G337789-5g
|
≥90% |
88-84-6 |
5g
|
¥ 399.9
|
现货 |
阿拉丁 |
愈创木烯
|
G337789-25g
|
≥90% |
88-84-6 |
25g
|
¥ 1329.9
|
现货 |
阿拉丁 |
吉非替尼盐酸盐
|
G337638-500mg
|
≥98% |
184475-55-6 |
500mg
|
¥ 926.9
|
现货 |
阿拉丁 |
吉非替尼盐酸盐
|
G337638-100mg
|
≥98% |
184475-55-6 |
100mg
|
¥ 411.9
|
现货 |
阿拉丁 |
双胍辛胺 乙酸盐
|
G335083-10mg
|
分析标准品 |
115044-19-4 |
10mg
|
¥ 399.9
|
现货 |
阿拉丁 |
肌醇半乳糖苷 水合物
|
G334783-50mg
|
≥95% |
16908-86-4 |
50mg
|
¥ 1296.9
|
现货 |
阿拉丁 |
溴化锗(II)
|
G333609-1g
|
≥97% |
24415-00-7 |
1g
|
¥ 1441.9
|
现货 |
阿拉丁 |
糖脂胆酸钠盐
|
G332584-25mg
|
≥98% |
24404-83-9 |
25mg
|
¥ 3243.9
|
现货 |
阿拉丁 |
糖脂胆酸钠盐
|
G332584-10mg
|
≥98% |
24404-83-9 |
10mg
|
¥ 1574.9
|
现货 |
阿拉丁 |
糖脂胆酸钠盐
|
G332584-100mg
|
≥98% |
24404-83-9 |
100mg
|
¥ 9083.9
|
现货 |
阿拉丁 |
葡萄糖五硫酸钾盐
|
G332043-5mg
|
≥98% |
359435-44-2 |
5mg
|
¥ 720.9
|
期货,请咨询 |
阿拉丁 |
5-[[1-[(4-甲基-2-氧代-苯并吡喃-7-基)氨基]-1-氧代-3-苯基-丙-2-基]氨基]-5-氧代-戊酸
|
G331450-5mg
|
≥98% |
58632-47-6 |
5mg
|
¥ 166.9
|
现货 |
阿拉丁 |
5-[[1-[(4-甲基-2-氧代-苯并吡喃-7-基)氨基]-1-氧代-3-苯基-丙-2-基]氨基]-5-氧代-戊酸
|
G331450-100mg
|
≥98% |
58632-47-6 |
100mg
|
¥ 1750.9
|
现货 |
阿拉丁 |
N-戊二酰基-甘氨酰-精氨酸-7-氨基-4-甲基香豆素盐酸盐
|
G331388-10mg
|
≥98% |
103213-40-7 |
10mg
|
¥ 535.9
|
现货 |
阿拉丁 |
N-戊二酰基-甘氨酰-精氨酸-7-氨基-4-甲基香豆素盐酸盐
|
G331388-100mg
|
≥98% |
103213-40-7 |
100mg
|
¥ 2574.9
|
现货 |
阿拉丁 |
甘氨酸-精氨酸-甘氨酸-天冬氨酸-丝氨酸
|
G305036-50mg
|
≥98% |
96426-21-0 |
50mg
|
¥ 4448.9
|
现货 |
阿拉丁 |
甘氨酸-精氨酸-甘氨酸-天冬氨酸-丝氨酸
|
G305036-10mg
|
≥98% |
96426-21-0 |
10mg
|
¥ 1389.9
|
现货 |
阿拉丁 |